Alexion
AcquiredAlexion Global Site
Boston, United States · Founded 1992
- Headquarters
- Boston, Massachusetts
- Employees
- 1001–5000
- Founded
- 1992
- Business Model
- B2B
- Website
- alexion.com
- Last Round
- SeedJun 1993
- Rounds
- 1
- Acquired by
- AstraZeneca PLCDec 2020 · $39.0B
About
Rare disease pharmaceutical company specializing in complement biology and orphan drugs; AstraZeneca subsidiary since 2021.
Summary
Alexion is a Biotech company based in Boston, United States, founded in 1992. Its most recent funding was a Seed round in Jun 1993. Investors include AstraZeneca and Venrock.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2020
Sign up to see all 3 rounds
IPO through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alexion"><img src="https://indexed.vc/api/badge/company/alexion" alt="Alexion on Indexed.vc" width="260" height="76" /></a>